BS

Bharat Srinivasa

Founder of Reverb Therapeutics

Toronto, Ontario

Overview 

Bharat Srinivasa is a Founder, Investor, and Partner based in Toronto, Ontario, with a background in biotechnology and life sciences. He has co-founded companies like Amplitude Ventures and Reverb Therapeutics, and served in key leadership roles such as Founding CEO and Board Director in various organizations in the pharmaceutical industry. Srinivasa's career highlights include founding successful ventures like Reverb Therapeutics and Radiant Biotherapeutics, showcasing his expertise in growth investing and commercialization strategies within the biotechnology sector. His current role involves actively investing in early-stage companies in the medical devices, consumer health, and biotech sectors, contributing to the growth and success of innovative healthcare startups.

Work Experience 

AV

Amplitude Ventures

  • Co-Founder and Principal

    2018 - Current

RT

Reverb Therapeutics

  • Co-Founder and Board Director

    2023

AB

Ability Biologics

  • Founding CEO and Board Observer

    2022

RB

Radiant Biotherapeutics

  • Founding CEO and Board Director

    2020

CT

Celsius Therapeutics

  • Board Observer

    2021 - 2024

    Acquired by Abbvie.

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.

Raised $148,000,000.00 from Catalio Capital Management, Amgen Ventures, Amplitude Venture Capital, Alexandria Venture Investments, Curie.Bio, Cowin Venture, Google Ventures, Casdin Capital, Section 32 and Fast Track Initiative, Inc..

celsiustx.com
SS

Surgical Safety Technologies Inc.

  • Independent Director - Board of Directors

    2022 - 2023

    Represent a major shareholder to guide the company on a $15M Series A financing, which was successfully closed in April 2023.

S

Saegis

  • Independent Director - Board of Directors

    2021 - 2022

    Independent Board member focussed on strategic discussions around partnerships/investments. Guided the organization in its reabsorbtion back into the parent (CMPA)

Angiochem

  • Board Director

    2018 - 2022

B

BDC

  • Investment team - Healthcare Venture Fund

    2015 - 2018

FR

Foster Rosenblatt

  • Business Intelligence, Forecasting & Valuation

    2014 - 2015

Foster Rosenblatt is an international advisory and training firm that focuses on life sciences.

fosterrosenblatt.com

Education 

Investments 

Reverb Therapeutics

Seed

Total funding amount not yet available

Radiant Biotherapeutics

Seed

Total funding: $8M

Articles About Bharat

Relevant Websites